MOGADON

This brand name is authorized in Austria, Australia, Canada, France, Ireland, Malta, United Kingdom

Active ingredients

The drug MOGADON contains one active pharmaceutical ingredient (API):

1 Nitrazepam UNII 9CLV70W7HS - NITRAZEPAM

Nitrazepam is a benzodiazepine compound with sedative properties. It acts in 30 to 60 minutes to produce sleep lasting 6 to 8 hours. Read about Nitrazepam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MOGADON Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05CD02	Nitrazepam	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2723H, 2732T, 5189D, 5359C
Country: CA	Health Products and Food Branch	Identifier(s): 00511528, 00511536
Country: FR	Base de données publique des médicaments	Identifier(s): 66205536
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 16308
Country: IE	Health Products Regulatory Authority	Identifier(s): 71455
Country: MT	Medicines Authority	Identifier(s): MA1507/01601